Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Contrasting pathology of the stress granule proteins TIA-1 and G3BP in tauopathies.

Vanderweyde T, Yu H, Varnum M, Liu-Yesucevitz L, Citro A, Ikezu T, Duff K, Wolozin B.

J Neurosci. 2012 Jun 13;32(24):8270-83. doi: 10.1523/JNEUROSCI.1592-12.2012.

2.

Pathological stress granules in Alzheimer's disease.

Ash PE, Vanderweyde TE, Youmans KL, Apicco DJ, Wolozin B.

Brain Res. 2014 Oct 10;1584:52-8. doi: 10.1016/j.brainres.2014.05.052.

3.
4.

Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies.

Ramakrishnan P, Dickson DW, Davies P.

Neurobiol Dis. 2003 Nov;14(2):251-64.

PMID:
14572447
5.
6.

MSUT2 is a determinant of susceptibility to tau neurotoxicity.

Guthrie CR, Greenup L, Leverenz JB, Kraemer BC.

Hum Mol Genet. 2011 May 15;20(10):1989-99. doi: 10.1093/hmg/ddr079.

7.

Age-dependent effects of microglial inhibition in vivo on Alzheimer's disease neuropathology using bioactive-conjugated iron oxide nanoparticles.

Glat M, Skaat H, Menkes-Caspi N, Margel S, Stern EA.

J Nanobiotechnology. 2013 Sep 23;11:32. doi: 10.1186/1477-3155-11-32.

8.

Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies.

Wilhelmus MM, de Jager M, Rozemuller AJ, Brevé J, Bol JG, Eckert RL, Drukarch B.

J Pathol. 2012 Jan;226(1):132-42. doi: 10.1002/path.2984.

9.

Herpes simplex virus 2 infection impacts stress granule accumulation.

Finnen RL, Pangka KR, Banfield BW.

J Virol. 2012 Aug;86(15):8119-30. doi: 10.1128/JVI.00313-12.

10.

Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology.

Dabir DV, Trojanowski JQ, Richter-Landsberg C, Lee VM, Forman MS.

Am J Pathol. 2004 Jan;164(1):155-66.

11.

TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1.

McDonald KK, Aulas A, Destroismaisons L, Pickles S, Beleac E, Camu W, Rouleau GA, Vande Velde C.

Hum Mol Genet. 2011 Apr 1;20(7):1400-10. doi: 10.1093/hmg/ddr021.

PMID:
21257637
12.

Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy.

Iba M, Guo JL, McBride JD, Zhang B, Trojanowski JQ, Lee VM.

J Neurosci. 2013 Jan 16;33(3):1024-37. doi: 10.1523/JNEUROSCI.2642-12.2013.

13.

Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain.

Kopeikina KJ, Carlson GA, Pitstick R, Ludvigson AE, Peters A, Luebke JI, Koffie RM, Frosch MP, Hyman BT, Spires-Jones TL.

Am J Pathol. 2011 Oct;179(4):2071-82. doi: 10.1016/j.ajpath.2011.07.004.

14.

Selective tau tyrosine nitration in non-AD tauopathies.

Reyes JF, Geula C, Vana L, Binder LI.

Acta Neuropathol. 2012 Jan;123(1):119-32. doi: 10.1007/s00401-011-0898-8.

15.

Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections.

Iba M, McBride JD, Guo JL, Zhang B, Trojanowski JQ, Lee VM.

Acta Neuropathol. 2015 Sep;130(3):349-62. doi: 10.1007/s00401-015-1458-4.

16.

Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.

Lewis J, Dickson DW.

Acta Neuropathol. 2016 Jan;131(1):27-48. doi: 10.1007/s00401-015-1507-z. Review.

PMID:
26576562
17.

Microglial activation in brain lesions with tau deposits: comparison of human tauopathies and tau transgenic mice TgTauP301L.

Sasaki A, Kawarabayashi T, Murakami T, Matsubara E, Ikeda M, Hagiwara H, Westaway D, George-Hyslop PS, Shoji M, Nakazato Y.

Brain Res. 2008 Jun 12;1214:159-68. doi: 10.1016/j.brainres.2008.02.084.

PMID:
18457819
18.

[Neuropathology of tauopathy].

Yoshida M.

Brain Nerve. 2013 Dec;65(12):1445-58. Review. Japanese.

PMID:
24323931
19.

Sources of extracellular tau and its signaling.

Avila J, Simón D, Díaz-Hernández M, Pintor J, Hernández F.

J Alzheimers Dis. 2014;40 Suppl 1:S7-S15. doi: 10.3233/JAD-131832. Review.

PMID:
24531154
20.

Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice.

Bolmont T, Clavaguera F, Meyer-Luehmann M, Herzig MC, Radde R, Staufenbiel M, Lewis J, Hutton M, Tolnay M, Jucker M.

Am J Pathol. 2007 Dec;171(6):2012-20.

Supplemental Content

Support Center